Susan M. Kelliher - Mar 1, 2023 Form 4 Insider Report for Chemours Co (CC)

Role
SVP, People and Health Service
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Mar 1, 2023
Transactions value $
-$32,088
Form type
4
Date filed
3/3/2023, 08:19 PM
Previous filing
Feb 14, 2023
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Tax liability -$32.1K -921 -1.08% $34.84 84.3K Mar 1, 2023 Direct F1, F2
transaction CC Common Stock Award $0 +5.02K +5.96% $0.00 89.3K Mar 1, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Award $0 +11.4K $0.00 11.4K Mar 1, 2023 Common Stock 11.4K $34.84 Direct F4
transaction CC Performance Stock Option (Right to Buy) Award $0 +11.2K $0.00 11.2K Mar 1, 2023 Common Stock 11.2K $38.32 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
F2 Includes directly owned shares, restricted stock units and dividend equivalent units.
F3 Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.
F4 These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
F5 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant